24 May 2013
Keywords: afssaps, gives, ok, ph, iii, genasense, trial
Article | 22 October 2007
USA-based Genta says that the French Health Products Safety Agency (AFSSAPS) has granted authorization to open the company's Phase III
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 October 2007
29 October 2007
© 2013 thepharmaletter.com